-
Face Mask Sensor Detects Covid-19 Virus
Engineers designed sensors made from bioactive materials integrated into fabrics, beginning with a face mask that detects the SARS-CoV-2 virus.
-
New Science & Enterprise Email Alerts
From our earliest days, Science & Enterprise readers could subscribe to daily email alerts providing titles, summaries, and links to our posts that day.
-
Trial Shows In-Body Crispr Therapy Feasibility
Early clinical trial data show gene editing with Crispr performed inside the body can correct an inherited neurological condition, with few adverse effects.
-
Infographic – Digital Divide Continues Across Platforms
Despite gains with smartphones, people with lower incomes in the U.S. continue to use digital technologies less than those with higher incomes.
-
Long-Acting Capsule Helps Reduce Opioid Use
A capsule designed to take once a week is shown in animal tests to continuously deliver a craving-reduction drug in that time and suppress opioid intake.
-
Biotechs Partner on Lower Cost AI-Designed Drugs
Two biotechnology companies are collaborating on discovery and development of new drugs designed with artificial intelligence, at lower cost to patients.
-
Micro Brain Robot Granted Orphan Status
A tiny remote-controlled device that carries chemotherapy drugs to brain tumors received orphan drug status from the Food and Drug Administration.
-
Challenge Seeks Reliable Depression Diagnostics, Models
A new competition seeks reliable biological methods for detecting depression and decision models that connect diagnostics to effective disease treatments.
-
Future Of Medicine With New Technologies
Since the Covid-19 times, more people within medicine have decided to take a different approach to medicine.
-
FDA Okays Trial of Donated Stem Cells for Parkinson’s
An organization studying stem cell therapies says it received FDA authorization for a clinical trial to test donated stem cells to treat Parkinson’s disease.